REQUEST A DEMO
Total
USD $0.00
Search more companies

Ciruderma Sas (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Ciruderma Sas Profile Updated: March 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Ciruderma Sas is an enterprise based in Colombia. Its main office is in Bogota D.C.. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on March 27, 2007. The total number of employees is currently 50 (2025). In its most recent financial highlights, the company reported a net sales revenue drop of 0.83% in 2024. Its’ total assets recorded a negative growth of 22.85%.

Headquarters
Calle 106 # 53 - 39 Edificio Cosmopolitan Oficina 201
Bogota D.C.; Bogota D.C; Postal Code: 0822

Contact Details: Purchase the Ciruderma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Ciruderma Sas report to view the information.
Registered Capital:
Purchase the Ciruderma Sas report to view the information.
Financial Auditors:
Purchase the Ciruderma Sas report to view the information.
Incorporation Date:
March 27, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Ciruderma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-0.83%
Total operating revenue
-1.92%
Operating profit (EBIT)
-68.08%
EBITDA
-54.81%
Net Profit (Loss) for the Period
N/A
Total Assets
-22.85%
Total Equity
-11.01%
Operating Profit Margin (ROS)
-5.31%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
0.5%
Quick Ratio
0.23%
Cash Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?